The purpose of this study is to analyze the early clinical features of coronary artery lesion (CAL) in Kawasaki disease (KD), evaluate systemic inflammation indicators, and enhance early recognition of CAL in the acute phase of KD. A total of 314 children with KD were divided into those with CAL (CAL group) and without CAL (NCAL group) using echocardiographic results, and their clinical data were retrospectively analyzed. For KD patients, male, children aged 3 to 9 years, and those with fever longer than 6 days before intravenous immunoglobulin (IVIG) use were more likely to have CAL. There were significant differences in sex, age, and fever time (P < .05). Moreover, some laboratory indicator test results revealed there was a significant difference between N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and interleukin-6 (IL-6), and the CAL (P < .05). This study has certain guiding significance for early clinical evaluation.
MccrindleBWLiJSMinichLA, et al. Coronary artery involvement in children with Kawasaki disease. Circulation. 2007;116(2):1747-1749.
2.
FangLYingHGBaoDJ, et al. Recommendations for the clinical management of Kawasaki disease with coronary artery lesions. Chinese J Pediatr. 2012;50(2):746-749.
3.
XieTWangYFuS, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatric Rheum. 2017;15(1):17.
4.
PahlESehgalRChrystofD, et al. Feasibility of exercise stress echocardiography for the follow-up of children with coronary involvement secondary to Kawasaki disease. Circulation. 1995;91(1):122-128.
5.
LiYZhengQZouL, et al. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition. Pediatric Rheum. 2019;17(1):1.
6.
HuYM.Zhufutang Practical Pediatrics. 8th ed.Beijing: People’s Health Agency; 2014.
7.
ShulmanSTRowleyAH.Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol. 2015;11(8):475-482.
8.
LuXZhaoXZhangX, et al. Advances in the biological markers of Kawasaki disease. Int J Pediatrics. 2020;47(1):14-17.
9.
MaLWangJLinJ.Predictor of the first dose of immunoglobulin resistance in children with Kawasaki disease. J Xi’an Jiaotong Univ. 2020;41(4):559-564.
10.
KangJHHongSJSeoIA, et al. Early detection of Kawasaki disease in infant. Korean Circ J. 2015;45(6):510-515.
11.
YoonYMYunHWKimSH.Clinical characteristics of Kawasaki disease in infants younger than six months: a single-center study. Korean Circ J. 2016;46(4):550-555.
12.
LiuGDuZH.Diagnosis and treatment of incomplete Kawasaki disease. Pediatr Emerg Med China. 2020;27(9):666-670.
13.
ZhouQWuJQiuH.Progress in the etiology and pathogenesis of Kawasaki disease. Zhejiang Med. 2019;41(13):1443-1446.
14.
ZhouYWangSZhaoJFangP.Correlations of complication with coronary arterial lesion with VEGF, PLT, D-dimer and inflammatory factor in child patients with Kawasaki disease. Eur Rev Med Pharmacol Sci. 2018;22(16):5121-5126.
15.
MccrindleBWRowleyAHNeburgerJW, et al. Diagnosis, treatment, and Long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927-e999.
16.
BilalMHaseebASaeedA, et al. The importance of serum N-terminal pro-brain natriuretic peptide and endogenous hydrogen sulfide for predicting coronary artery lesions in pediatric Kawasaki disease patients: findings from a tertiary care hospital in Karachi, Pakistan. Cureus. 2020;12(7):1-8.
17.
SongHZhangYDongQ, et al. Significance of Serum NT-pro-BNP and endogenous H2S for predicting coronary artery lesions in pediatric Kawasaki disease. J Coll Physicians Surg Pak. 2020;30(1):37-40.
18.
KatoMAyusawaMWatanabeH, et al. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease. Pediatr Int. 2018;60(4):342-348.
19.
KwonHLeeJHJungJY, et al. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease. Eur J Pediatr. 2016;175:1997-2003.
20.
WuYLiuFFXuY, et al. Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm. Clin Exp Med. 2019;19(2):173-181.
21.
JinJWangJLuY, et al. Platelet-derived microparticles: a new index of monitoring platelet activation and inflammation in Kawasaki disease. Indian J Pediatr. 2019;86(3):250-255.
22.
NandiAPalPBasuS.A comparison of serum IL-6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study. Rheumatol Int. 2019;39:1797-1801.
23.
BordeaMACostacheCGramaA, et al. Cytokine cascade in Kawasaki disease versus Kawasaki-like syndrome. Physiol Res. 2022;71:17-27.
24.
ChangLYangHWLinTYYangKD.Perspective of immunopathogenesis and immunotherapies for Kawasaki disease. Front Pediatr. 2021;9:697632.
25.
Paniz-MondolfiAEvan den AkkerTMárquez-ColmenarezMCDelgado-NogueraLAValderramaOSordilloEM.Kawasaki disease seasonality in Venezuela supports an arbovirus infection trigger. J Med Virol. 2020;92(12):2903-2910.
26.
SuYFengSLuoL, et al. Association between IL-35 and coronary arterial lesions in children with Kawasaki disease. Clin Exp Med. 2019;19:87-92.
27.
IemuraMIshiiMSugimuraT, et al. Long consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart. 2000;83(3):307-311.
28.
Chennl YangCLiG, et al. Predictive value of the systemic immune-inflammation index for coronary dilation in children with Kawasaki disease. Chinese J Immunol. 2020;36(16):2003-2006.
29.
KhanAAGeorgeJVAl HamadSMSJayarajRLNarchiH.Serum biomarkers differentiating Kawasaki disease from febrile infections: a pilot case-control study. Saudi J Biol Sci. 2020;27(12):3428-3433.
30.
YangRMaJ.Application of echocardiography and myocardial enzymatic testing in diagnosis of Kawasaki disease with coronary lesions. Shanxi Medical J. 2020;49(10):1259-1265.
31.
HuangHLinSYuanL.Risk and clinical characteristics of acute-stage myocarditis in children with coronary artery lesions of Kawasaki disease. J Integr Tradit Chin West Med Cardiovasc Cerebrovasc Dis. 2020;18(18):3068-3070.
32.
ZhangXShaoYWZhangYL, et al. Serum Lp-PLA2 level predicting coronary artery Lesions in children with Kawasaki disease. Heart Surg Forum. 2021;24:611-618.
